《盈警響號》創夢天地(01119.HK)料去年虧損擴大至最多26億人幣
創夢天地(01119.HK)發盈警,預期截至去年12月底止年度將錄得淨虧損約24億元人民幣(下同)至26億元,期內收益約27億元至28億元。至於集團於2021年同期錄得淨虧損約1.56億元。
集團指,預期虧損擴大主要是由於集團對無形資產及預付內容供應商分成款進行減值撥備;集團對天津火魂網絡科技有限公司的業務收購進行商譽減值,對若干投資公司的公允價值變動確認虧損;集團預期對金融資產及合約資產計提減值撥備;及2022財年集團重點自研產品的研發投入。
集團透露,自去年下半年以來經營現金流明顯改善,今年首季保持更強勁的增長勢頭,目前經營性現金流約為1.8億元至2.2億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.